newsfilter
← Latest News
GlobeNewswire·

Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio

  • Wellspect HealthCare announced that its Surity™ portfolio, including the Surity™ Urinary Management System & external catheters, may be covered by traditional Medicare for eligible U.S. beneficiaries when medically necessary.
  • Reimbursement access is supported by specific Healthcare Common Procedure Coding System (HCPCS) codes: A6590 for the Surity™ Female & Male External Catheters & E2001 for the Surity™ Urinary Management System.
  • The non-invasive Surity™ solutions utilize gentle suction technology to provide discreet & reliable management for individuals living with permanent urinary incontinence.
  • This milestone aims to reduce barriers to care & expand options for the over 13 million people in the U.S. affected by urinary incontinence.
  • The Surity™ Urinary Management System was launched in the United States on August 18, 2026, completing the full portfolio following the introduction of the external catheters earlier in the year.
  • Since its introduction, the Surity™ brand has become one of the most searched external catheter brands on Google in the U.S.
  • Wellspect HealthCare, a subsidiary of Dentsply Sirona, provides additional information regarding coverage requirements & eligibility at www.surity.care.
  • Medicare coverage decisions remain subject to individual situations & payer determinations, with no guarantee of reimbursement provided by Wellspect.